Increasing libido in humans via acute testosterone administration
US6632419B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Mar 19, 2001 |
| Grant date | Oct 14, 2003 |
| Priority date | — |
| Expiry date | Mar 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The libido of adult human female patients is increased by the bolus delivery of a testosterone which is preferably dihydrotestosterone. The formulation is preferably aerosolized and inhaled into a patient's lungs where particles of testosterone deposits on lung tissue and then enter the patient's circulatory system. The patient's testosterone level is quickly enhanced well above baseline levels for a short period and subsides to baseline levels with normal metabolism thereby providing desired short term effects on enhanced libido without undesirable effects of long term enhanced testosterone levels. Additional formulations are provided including formulations for aerosolized delivery of sildenafil citrate which are delivered to male or female patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.